Pirmdiena, 2026. gada 02. novembris 22:49
Vārda dienas: Dzīle, Viva, Vivita
The Lithuanian pharmaceutical company Biotechna, which produces gene-engineering medicine, is projecting a one-fifth increase in sales this year and intends to start selling its production in Western markets in 2003-2004.
Rakstu var komentēt tikai reģistrēti lietotāji!
